FULLER GILBERT A 4

What Happened
Gilbert A. Fuller, a director of USANA Health Sciences, was granted 6,527 restricted stock units (RSUs) on May 7, 2026. The award shows an acquisition price of $0 (a compensatory grant/derivative award); the RSUs represent a contingent right to receive one share of USANA common stock per unit upon vesting.

Key Details

• Transaction date: May 7, 2026; filing date: May 11, 2026 (filed within the two-business-day reporting window).
• Transaction type/code: Award/Grant (A); 6,527 RSUs granted at $0.00 (derivative security).
• Vesting schedule (per filing footnote): 25% vest on July 23, 2026; 25% on Oct 22, 2026; 25% on Jan 21, 2027; 25% on Apr 22, 2027.
• Footnote: Each RSU equals the right to one share upon settlement.
• Shares owned after the transaction: Not specified in the filing.

Context
RSUs are compensation grants that convert into actual shares only as they vest; they are not an open-market purchase or immediate sale. Grants are routine for director and executive compensation and do not by themselves indicate a near-term buy/sell decision.